Clinical Trial Update: Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia [Phase 1]

View source ↗

Summary

Phase 1 trial of idebenone to treat Friedreich's ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Friedreich Ataxia | Phase 1 | Status: COMPLETED